Revolutionizing Transdermal Delivery with LMS-BG

Transdermal drug delivery is evolving rapidly, yet traditional dissolving microneedles (DMNs) face significant clinical hurdles. The diffusion of drugs into the backing layer during production often reduces dose accuracy. Moreover, many existing systems suffer from slow dissolution rates and mechanical fragility. To address these barriers, researchers developed Lyophilized Microneedle Systems using Biocompatible Glue (LMS-BG). This modular platform ensures efficient drug localization and rapid onset, specifically designed for clinical viability.

How Lyophilized Microneedle Systems Enhance Performance

The LMS-BG architecture consists of a drug-loaded tip coupled with a prefabricated backing through a biodegradable, ethanol-based glue. This biocompatible glue (BC glue) provides two vital functions. First, it ensures that the drug remains confined to the microneedle tip rather than migrating into the backing material. Second, the glue partially interpenetrates the porous, lyophilized structure to reinforce the needles mechanically. Consequently, these needles can penetrate the skin effectively despite their amorphous microstructure. Furthermore, this reinforcement prevents the typical fragility associated with porous materials.

Clinical Efficacy and Speed

Using lidocaine hydrochloride (LiH) as a model drug, this system demonstrated remarkable performance in laboratory and animal tests. In comparative evaluations, the LMS-BG achieved an 11-fold faster dissolution rate than conventional microneedle systems. Additionally, the platform retained over 96% of the drug within the tip. Within just two minutes of application, the transdermal delivery efficiency exceeded 90%. In vivo studies in rat models also confirmed that LMS-BG provides superior local anesthetic effects compared to commercial gels. Ultimately, the system provides excellent biocompatibility while maintaining high mechanical strength for successful skin insertion.

Scalability and Modular Applications

The versatility of the LMS-BG fabrication method is one of its most promising features. Researchers successfully extended the technology to platforms using soluble polymers, hydrogels, and even PLGA nanoparticles. This modularity suggests that the system can be scaled for various therapeutic agents beyond local anesthetics. In addition, the prefabricated backing approach allows for mass production without compromising the stability of sensitive drugs. This study addresses the primary translational barriers of traditional microneedles, offering a robust path for modern medical practice.

Frequently Asked Questions

What is the main advantage of the LMS-BG system?

The LMS-BG system significantly accelerates drug dissolution, reaching an 11-fold faster rate than conventional dissolving microneedles. It also ensures that nearly all the medication stays in the needle tip for maximum delivery efficiency.

Why is biocompatible glue used in these microneedles?

The biocompatible glue anchors the drug-loaded tip to the backing and reinforces the porous structure. This design prevents drug waste and provides the mechanical strength needed to pierce the skin barrier effectively.

How fast does the LMS-BG system deliver medication?

The system is highly efficient, delivering over 90% of its drug payload within just two minutes of application. This makes it significantly faster than standard anesthetic creams or traditional microneedle patches.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Kim ST et al. Biocompatible Glue-Enabled Drug Localization and Mechanical Reinforcement of Lyophilized Microneedle Systems. Small. 2026 Feb 07. doi: 10.1002/smll.202512379. PMID: 41653461.

Zhu J et al. Enhanced Transdermal Delivery of Lidocaine Hydrochloride via Dissolvable Microneedles (LH-DMNs) for Rapid Local Anesthesia. Pharmaceutics. 2025 Aug 21;17(8):1245.

Zhang X et al. Lidocaine-Loaded Hyaluronic Acid Adhesive Microneedle Patch for Oral Mucosal Topical Anesthesia. MDPI Pharmaceutics. 2022 Mar 22;14(4):689.